Clinical Management and Pathophysiology of Infective Endocarditis: An Updated Review of Diagnostic Challenges and Therapeutic Approaches

Main Article Content

Donaldo Emiliano Silva López
Pedro Luis Matus Rojo
Rubén Darío González Tellechea
Brenda Paola Flores González
Elissa Bracamontes Perez
Manuel Rodrigo Toledo Burgueño

Abstract

Infective endocarditis (IE) is a severe and life-threatening condition characterized by infection of the endocardial surface of the heart, primarily affecting the heart valves. Despite advances in diagnostic techniques and antimicrobial therapies, IE remains associated with significant morbidity and mortality due to its complex pathogenesis and clinical variability. This article reviews the most recent developments in the pathophysiology, diagnostic criteria, and management strategies of infective endocarditis. Key issues such as microbial etiology, including common pathogens like Staphylococcus aureus and Streptococcus species, are discussed alongside less frequent organisms and their association with specific patient populations. The article emphasizes the importance of early diagnosis using advanced imaging modalities, such as echocardiography and PET-CT, and laboratory findings, particularly blood cultures. We explore both medical and surgical management strategies, highlighting the role of antibiotic therapy and the indications for valve surgery. A focus is given to the management of complex cases, including prosthetic valve endocarditis and infections in immunocompromised patients. The article aims to provide clinicians with a comprehensive understanding of the evolving landscape of infective endocarditis and its implications for patient outcomes.

Article Details

How to Cite
Donaldo Emiliano Silva López, Pedro Luis Matus Rojo, Rubén Darío González Tellechea, Brenda Paola Flores González, Elissa Bracamontes Perez, & Manuel Rodrigo Toledo Burgueño. (2024). Clinical Management and Pathophysiology of Infective Endocarditis: An Updated Review of Diagnostic Challenges and Therapeutic Approaches. International Journal of Medical Science and Clinical Research Studies, 4(10), 1883–1889. https://doi.org/10.47191/ijmscrs/v4-i10-29
Section
Articles

References

I. Geller, SA Infective endocarditis: a history of the development of its understanding Autops Case Rep. 2013; 3:5-12

II. Lerner, PI ∙ Weinstein, L Infective endocarditis in the antibiotic era N Engl J Med. 1966; 274:199-206

III. Lerner, PI ∙ Weinstein, L Infective endocarditis in the antibiotic era N Engl J Med. 1966; 274:259-266

IV. Lerner, PI ∙ Weinstein, L Infective endocarditis in the antibiotic era N Engl J Med. 1966; 274:388-393

V. Hackett, AJ ∙ Stuart, J Infective endocarditis: identification and management in the emergency department Emerg Med Pract. 2020; 22:1-24

VI. Wang, A ∙ Athan, E ∙ Pappas, PA ∙ et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis JAMA. 2007; 297:1354-1361

VII. Chen, H ∙ Zhan, Y ∙ Zhang, K ∙ et al. The global, regional, and national burden and trends of infective endocarditis from 1990 to 2019: results from the Global Burden of Disease Study 2019 Front Med. 2022; 9, 774224

VIII. Tleyjeh, IM ∙ Steckelberg, JM ∙ Murad, HS ∙ et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota JAMA. 2005; 293:3022-3028

IX. Slipczuk, L ∙ Codolosa, JN ∙ Davila, CD ∙ et al. Infective endocarditis epidemiology over five decades: a systematic review PLoS One. 2013; 8, e82665

X. Polishchuk, I ∙ Stavi, V ∙ Awesat, J ∙ et al. Sex differences in infective endocarditis Am J Med Sci. 2021; 361:83-89

XI. Hammond-Haley, M ∙ Hartley, A ∙ Al-Khayatt, BM ∙ et al. Trends in the incidence and mortality of infective endocarditis in high-income countries between 1990 and 2019 Int J Cardiol. 2023; 371:441-451

XII. Shah, ASV ∙ McAllister, DA ∙ Gallacher, P ∙ et al. Incidence, microbiology, and outcomes in patients hospitalized with infective endocarditis Circulation. 2020; 141:2067-2077

XIII. Li, HL ∙ Tromp, J ∙ Teramoto, K ∙ et al. Temporal trends and patterns of infective endocarditis in a Chinese population: a territory-wide study in Hong Kong (2002–2019) Lancet Reg Health West Pac. 2022; 22, 100417

XIV. Yucel, E ∙ Bearnot, B ∙ Paras, ML ∙ et al. Diagnosis and management of infective endocarditis in people who inject drugs: JACC state-of-the-art review J Am Coll Cardiol. 2022; 79:2037-2057

XV. Sengupta, SP ∙ Prendergast, B ∙ Laroche, C ∙ et al. Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry Eur Heart J Qual Care Clin Outcomes. 2022; 9:85-96

XVI. Noubiap, JJ ∙ Nkeck, JR ∙ Kwondom, BS ∙ et al. Epidemiology of infective endocarditis in Africa: a systematic review and meta-analysis Lancet Glob Health. 2022; 10:e77-e86

XVII. Njuguna, B ∙ Gardner, A ∙ Karwa, R ∙ et al. Infective endocarditis in low- and middle-income countries Cardiol Clin. 2017; 35:153-163

XVIII. Murdoch, DR ∙ Corey, GR ∙ Hoen, B ∙ et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study Arch Intern Med. 2009; 169:463-473

Most read articles by the same author(s)

<< < 1 2